277 related articles for article (PubMed ID: 15632042)
1. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
Miao Y; Hoffman TJ; Quinn TP
Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579
[TBL] [Abstract][Full Text] [Related]
3. Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues.
Miao Y; Fisher DR; Quinn TP
Nucl Med Biol; 2006 Aug; 33(6):723-33. PubMed ID: 16934691
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.
Miao Y; Whitener D; Feng W; Owen NK; Chen J; Quinn TP
Bioconjug Chem; 2003; 14(6):1177-84. PubMed ID: 14624632
[TBL] [Abstract][Full Text] [Related]
5. Melanoma therapy via peptide-targeted {alpha}-radiation.
Miao Y; Hylarides M; Fisher DR; Shelton T; Moore H; Wester DW; Fritzberg AR; Winkelmann CT; Hoffman T; Quinn TP
Clin Cancer Res; 2005 Aug; 11(15):5616-21. PubMed ID: 16061880
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of a 177Lu-labeled DOTA conjugated alpha-melanocyte-stimulating hormone peptide in a murine melanoma-bearing mouse model.
Miao Y; Shelton T; Quinn TP
Cancer Biother Radiopharm; 2007 Jun; 22(3):333-41. PubMed ID: 17651039
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy.
Miao Y; Owen NK; Whitener D; Gallazzi F; Hoffman TJ; Quinn TP
Int J Cancer; 2002 Oct; 101(5):480-7. PubMed ID: 12216078
[TBL] [Abstract][Full Text] [Related]
8. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
9. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
Miao Y; Benwell K; Quinn TP
J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.
Yang J; Guo H; Gallazzi F; Berwick M; Padilla RS; Miao Y
Bioconjug Chem; 2009 Aug; 20(8):1634-42. PubMed ID: 19552406
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
Yang J; Hu CA; Miao Y
Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051
[TBL] [Abstract][Full Text] [Related]
13. Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting.
Chen J; Cheng Z; Miao Y; Jurisson SS; Quinn TP
Cancer; 2002 Feb; 94(4 Suppl):1196-201. PubMed ID: 11877745
[TBL] [Abstract][Full Text] [Related]
14. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
15. Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.
Cantorias MV; Figueroa SD; Quinn TP; Lever JR; Hoffman TJ; Watkinson LD; Carmack TL; Cutler CS
Nucl Med Biol; 2009 Jul; 36(5):505-13. PubMed ID: 19520291
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.
Chen J; Cheng Z; Owen NK; Hoffman TJ; Miao Y; Jurisson SS; Quinn TP
J Nucl Med; 2001 Dec; 42(12):1847-55. PubMed ID: 11752084
[TBL] [Abstract][Full Text] [Related]
17. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP
Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001
[TBL] [Abstract][Full Text] [Related]
18. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
19. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
20. Effects of amino acids on melanoma targeting and clearance properties of Tc-99m-labeled Arg-X-Asp-conjugated α-melanocyte stimulating hormone peptides.
Flook AM; Yang J; Miao Y
J Med Chem; 2013 Nov; 56(21):8793-802. PubMed ID: 24131154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
